Hennermann, J. B.
Development of new therapies for rare diseases. Example: lysosomal storage disordersMONATSSCHRIFT KINDERHEILKUNDE. Bd. 165. H. 3. 2017 S. 226-232
Mengel, Eugen; Pineda, Mercedes; Hendriksz, Christian J. et al.
Differences in Niemann-Pick disease Type C symptomatology observed in patients of different agesMOLECULAR GENETICS AND METABOLISM. Bd. 120. H. 3. 2017 S. 180-189
Kowalzik, F; Knuf, M
Durch Rotaviren verursachte Gastroenteritiden in DeutschlandKinder- und Jugendmedizin; Infektionskrankheiten und Impfprävention. Bd. 4. 2017 S. 1-7
Stoessel, S.; Neu, M. A.; Wingerter, A. et al.
Effects of Combined Resistance and Endurance Training in Pediatric Cancer Patients during Intensive Treatment Phase: Design and First Insights into the MUCKI-StudyPEDIATRIC BLOOD & CANCER. Bd. 64. 2017 S. S139-S140
Beetz, Rolf; Stehr, Maximilian
Epididymitis in Children: Fact or FictionAKTUELLE UROLOGIE. Bd. 48. H. 5. 2017 S. 437-442
Posa, Daniela; Perna, Serena; Resch, Yvonne et al.
Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of lifeJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 139. H. 2. 2017 S. 541-+
Mehta, Atul; Belmatoug, Nadia; Bembi, Bruno et al.
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physiciansMOLECULAR GENETICS AND METABOLISM. Bd. 122. H. 3. 2017 S. 122-129
Solyom, Alexander; Nwosu, Ekene O.; Mitchell, John et al.
Farber disease (acid ceramidase deficiency) epidemiology: literature review and patient cohort data indicate moderate and attenuated phenotypes are likely underrepresented in the medical literature and are underdiagnosedMOLECULAR GENETICS AND METABOLISM. Bd. 120. H. 1-2. 2017 S. S124-S125
Solyom, Alexander; Mitchell, John; Beck, Michael et al.
Farber disease: design of the first observational and cross-sectional cohort study capturing retrospective and prospective data on the natural history and phenotypic spectrum of patients, including novel methodologies for assessment of disease-specific symptomsMOLECULAR GENETICS AND METABOLISM. Bd. 120. H. 1-2. 2017 S. S125-S125
Creutzig, Ursula; Dworzak, Michael N.; Bochennek, Konrad et al.
First experience of the AML-Berlin-Frankfurt-Munster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidPEDIATRIC BLOOD & CANCER. Bd. 64. H. 8. 2017